mental wellbeing, tension
Conditions
Interventions
Participants will ingest daily with breakfast 270 mg microalgae powder or
placebo capsules for 8 weeks
Sponsors
Solabia BV
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: • Age 18-35 years old • BMI between 18 and 30 kg/m2 • Willing to abstain from nutritional supplements known to affect the study outcome (e.g., ashwagandha, omega-3 fatty acids, rhodiola, vitamin c, and magnesium)
Exclusion criteria
Exclusion criteria: • Currently smoking or quitted smoking in the past year • Allergy to an ingredient of the product • Having donated blood within one month prior to the start of the study, or planning to donate blood during the study • Use of medication known to affect the outcomes of the study • Irregular menstrual cycle • Adrenal gland diseases (such as Addison*s disease and Cushing*s syndrome) • Prader-Willi syndrome • Known pregnancy or lactation • Shift workers • Major psychiatric/mental health disorders (e.g., depression, anxiety, post-traumatic stress) • Diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective is to assess the effect of 8 weeks of supplementing daily 270 mg microalgae powder on the stress response | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objective are to study the effects on mental wellbeing with the aid of questionnaires and measuring physiological markers such as BDNF and GABA. An exploratory study objective ais to study the effect on the microalgae supplementation on cognition. | — |
Countries
Netherlands
Contacts
Public ContactSolabia BV Solabia BV
Solabia BV
Outcome results
None listed